Showing results (191-200 of 519) with videos related to

Sort By:
Pageof 52
The American Review of Respiratory Disease|September 1, 1992
Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patientsT Gislason, J Hedner, L Terenius, et al.
Peptides|January 1, 1981
Avian pancreatic polypeptide (APP) immunoreactive neurons in the spinal cord and spinal trigeminal nucleusT Hökfelt, J M Lundberg, L Terenius, et al.
Brain & Development|January 1, 1990
CSF beta-endorphins in childhood neuropsychiatric disordersC Gillberg, L Terenius, B Hagberg, et al.
Chest|August 1, 1989
Increased CSF opioid activity in sleep apnea syndrome. Regression after successful treatmentT Gislason, M Almqvist, G Boman, et al.
European Journal of Pharmacology|August 15, 1996
N-Methyl-D-aspartate-induced enhancement of activator protein-1 DNA binding activity is blocked by ethanol in cerebellar granule cellsY N Hou, G Cebers, A Cebere, et al.
Neuroscience|August 1, 1993
Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brainM N Castel, P Morino, P Frey, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|December 1, 1994
Characterization of growth hormone binding sites in rat brainQ Zhai, Z Lai, P Roos, et al.
Brain Research|January 8, 1993
CGRP-like immunoreactivity in A11 dopamine neurons projecting to the spinal cord and a note on CGRP-CCK cross-reactivityC Orazzo, V A Pieribone, S Ceccatelli, et al.
European Journal of Pharmacology|March 15, 1988
Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance PM Reid, M Herrera-Marschitz, T Hökfelt, et al.
European Journal of Pharmacology|July 13, 1984
Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the ratM Herrera-Marschitz, T Hökfelt, U Ungerstedt, et al.
Pageof 52